Conference Reports for NATAP

63rd Annual Meeting of the American Association for the Study of Liver Diseases Boston, MA Nov 9-12 2012 Back

In Vitro Analyses of Hepatitis C Virus NS5B S282T Mutants in Multiple HCV Genotypes Show Low Levels of Reduced Susceptibility to Sofosbuvir (GS-7977), No Cross Resistance to Other Classes of Direct-Acting Antivirals, and Hypersensitivity to Ribavirin       Reported by Jules Levin AASLD Nov 9-13 Boston 2012   Bin Han, Hongmei Mo, Kelly A. Wong Gilead Sciences, Inc., Foster City, CA